Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibiotic formulary selection

H M Crowe1, R Quintiliani

  • 1Division of Infectious Diseases, Hartford Hospital, Connecticut, USA.

The Medical Clinics of North America
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bidirectional analysis of the association between migraine and post-traumatic stress disorder in Nurses' Health Study II.

Epidemiology and psychiatric sciences·2024
Same author

Antibiotic prophylaxis in eyes with filtration blebs: survey of glaucoma specialists, microbiological study, and recommendations.

Journal of glaucoma·2009
Same author

Infusion phlebitis: relative incidence associated with cefuroxime administered by intermittent and continuous infusion.

Clinical drug investigation·2008
Same author

Clinical management of respiratory tract infections in the community: experience with telithromycin.

Infection·2002
Same author

Antibacterials for the prophylaxis and treatment of bacterial endocarditis in children.

Paediatric drugs·2001
Same author

Moxifloxacin does increase the corrected QT interval.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

This study demonstrates how to create a cost-effective antibiotic formulary. By analyzing drug pharmacokinetics, implementing restriction policies, and performing cost-benefit analysis, healthcare providers can manage rising antibiotic costs.

Area of Science:

  • Pharmacoeconomics
  • Infectious Disease Management
  • Hospital Pharmacy Administration

Background:

  • Rising antibiotic expenditures represent a significant challenge to hospital pharmacy budgets globally.
  • Physicians face increasing pressure to integrate economic considerations into patient care decisions.
  • Optimizing antibiotic use is crucial for both clinical outcomes and financial sustainability.

Purpose of the Study:

  • To develop a cost-effective antibiotic formulary for hospital settings.
  • To outline a methodology for optimizing antibiotic prescribing and procurement.
  • To address the economic challenges associated with antibiotic use in healthcare.

Main Methods:

  • Utilized principles of drug pharmacokinetics to inform selection and dosing strategies.

Related Experiment Videos

  • Implemented targeted antibiotic restriction policies to guide appropriate use.
  • Conducted a comprehensive cost-benefit analysis of formulary options.

    • Main Results:

    • The designed formulary demonstrated potential for significant cost savings.
    • Pharmacokinetic data supported the selection of drugs with favorable therapeutic and economic profiles.
    • Restriction policies effectively promoted the use of cost-effective agents.

    Conclusions:

    • A systematic approach combining pharmacokinetics, restriction, and cost-benefit analysis can yield a cost-effective antibiotic formulary.
    • This strategy enables hospitals to manage escalating antibiotic costs while maintaining quality patient care.
    • The findings provide a practical framework for antimicrobial stewardship programs aiming for economic efficiency.